Ragle Human Nutrition Center
Davis, California, 95616, United States
NCT Number: NCT01674231
The investigators hope to learn about the effects of whole grapes, in the form of freeze-dried grape powder, on markers of health. Phytochemical rich food consumption is associated with protection against chronic diseases such as cardiovascular disease (CVD) demonstrating the ability to modify endothelial function and lipemia, but exact causal mechanisms are still not well understood. The investigators will examine metabolic and mechanistic effects of consumption of whole grape powder in chronic as well as acute settings in response to meal challenges by testing blood samples to determine if markers of health have improved.
The central hypothesis of this project is that consumption of grapes in the form of a polyphenol-rich freeze-dried whole grape powder (WGP) will attenuate chronic and meal induced oxidative stress and inflammatory responses in obese individuals.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Davis, California, 95616, United States
The specific aims are to:
Health promotion and prevention of chronic diseases in the face of a continuing obesity epidemic is the most pressing public health issue today. Epidemiologic evidence supports a protective effect of plant food-rich dietary patterns, and an inverse relationship of fruit and vegetable consumption with chronic conditions like cardiovascular disease (CVD). However, the underlying causal mechanisms are not well understood. Prospective human studies examining consumption of polyphenol-rich whole grapes or their components have found benefits on markers of oxidative stress and blood lipids as have other food examples such as blackcurrant juice and strawberries. Putative mechanisms underlying the positive actions of polyphenol-rich grapes have been well described in recent reviews. A number of in-vitro cell culture and in-vivo animal studies with WGP and extracts support these mechanisms. However, relatively fewer human studies have been conducted examining biomarkers and potential mechanisms for attenuation of chronic inflammatory responses and meal-induced postprandial oxidative stress and inflammation in obese humans.
Obesity is a metabolic state recognized as being pro-inflammatory, leading to dysregulation of endothelial function, glucose and lipoprotein metabolism and cardiovascular risk. Consumption of high fat diets can further impair vascular reactivity in the postprandial period. Circulating MNC provide a representation of the overall inflammatory status of the body, which is accessible and can be used to examine mechanistic processes in response to chronic and meal-induced oxidative stress. Recent literature reports have described the effect of polyphenol-rich food consumption and Mediterranean diet patterns to reduce NF-κB activation as well as changes in downstream inflammatory gene expression in peripheral blood MNC's. Therefore, the proposed study will exploit this approach to examine short-term responses to a meal challenge as well as longer-term responses to daily consumption of whole grapes as assessed by plasma and mononuclear cell indices. This research will shed light on oxidant stress-related transcription factors and downstream gene targets involved in the anti-inflammatory effects of grape consumption in obese individuals who are at increased risk of chronic diseases.
Additional scientific data is needed to understand the links between diet and health and to develop effective dietary strategies to improve health outcomes, particularly in obesity. The use of polyphenol-rich whole grape powder to attenuate inflammatory mediators and biomarkers in blood and mononuclear cells of obese humans represents a targeted intervention approach in an at-risk population. The goal for the study is to examine the link between the beneficial effects of grapes as a food and health in a significant public health chronic disease. The outcomes of the study design will provide preliminary data which bridges well-controlled human translational research and fundamental research by examining cellular responses to grape consumption in a human clinical trial. The approach will generate new and unique data to extend scientific knowledge and allow for the development of a mechanistic component to a human feeding intervention.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
60g freeze-dried whole grape powder with 296mg polyphenols per day for 4 weeks.
60g control food (matched for calories, low in polyphenols, and indistinguishable from active intervention) per day for 4 weeks.
Time frame: After 4 week intervention
High sensitivity C reactive protein, TNF-alpha, IL-1beta, lL-6. Assessed at time 0, 1, 3, 5 hours of acute meal challenge and in fasting samples at the end of the intervention.
Time frame: After 4 week intervention
Oxidized low density lipoprotein, urinary F2-isoprostane.
Time frame: After 4 week intervention
Blood pressure, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, ESelectin.
Time frame: After 4 week intervention
Total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol, triglyceride level, apolipoproteinA1, apolipoproteinB100.
Time frame: After 4 week intervention
TLR4, SOCS-3, NADPH oxidase subunit p47phox, Nrf-2, p50 subunit, IL-1β, MMP-9, MCP-1.
University of California, Davis
Other
Pilot Study: The Effects of Whole Grapes on Markers of Health
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02037321
Arthritis, Body Weight
Toronto, Ontario, Canada
View Trial DetailsNCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsNCT06242535
Behavior, Behavioral Symptoms
Gillette, Wyoming, United States
View Trial DetailsNCT03712579
Body Weight, Cardiovascular Diseases
Loughborough, Leicestershire, United Kingdom
View Trial Details